The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Clinical trial NCT01492101 · COMPLETED

Trial details

NCT number: NCT01492101
Sponsor: Nektar Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Recurrent Breast Cancer Metastatic Breast Cancer

Start date: 2011-12-01
Primary completion: 2016-04-01
Enrollment: 852

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.